PCORI New Funding Opportunity: Q2 2026 Application Cycle Now Open

PCORI funds a kind of research that NIH and industry don't do well — comparative effectiveness studies that ask "which of the options currently available actually works better for which patients?" That's a different question from the one clinical trials typically answer. Regulatory trials compare a new drug to placebo; PCORI funds studies that compare two real-world treatment options head-to-head in the patients who actually receive care. The Q2 2026 cycle has updated priority areas and eligibility structure that differ from prior cycles. If you're developing a proposal, understanding those specifics before you write the LOI saves weeks of wasted effort.

What PCORI Funds — and What It Doesn't

The most important thing to understand before writing a PCORI proposal is what the agency will not fund. PCORI does not fund basic science, animal studies, or efficacy trials comparing a treatment to placebo. It funds comparative effectiveness research — studies with at least two active treatment comparators, conducted in real-world patient populations, generating evidence about which option works better for which patients under what circumstances.

The word "patient-centered" in PCORI's name has a specific operational meaning. Outcomes must matter to patients, not just to clinicians or payers. A study comparing biomarker response rates without measuring patient-reported quality of life is unlikely to score well. Reviewers assess whether the study addresses questions that patients themselves have identified as important — ideally documented through formal stakeholder engagement during proposal development. The agencies that do this well treat patient engagement as a scientific methodology, not a public relations requirement.

Q2 2026 Funding Opportunity Breakdown

• Pragmatic Clinical Studies (PCS): PCORI's flagship funding mechanism. These are large-scale comparative effectiveness trials embedded in real clinical care settings — not standalone research facilities — comparing two or more interventions, exposures, or care strategies. Awards up to $30M over 4–6 years. The design requirement is pragmatism: the study must be feasible within routine care workflows, with eligibility criteria broad enough to reflect the actual patient population. Expect significant infrastructure investment in EHR integration and site coordination.
• Patient-Centered Outcomes Research (PCOR) Awards: A broader mechanism covering smaller comparative effectiveness studies, mixed-methods research, and observational studies with comparative elements. Awards typically $750K–$5M over 2–4 years. These are appropriate for early-career investigators or teams addressing well-defined comparative questions in a single disease area or patient population.
• Evidence Synthesis Awards: Systematic reviews, network meta-analyses, and rapid evidence reviews on comparative effectiveness questions from PCORI's prioritized research agenda. Awards up to $1.5M. PCORI publishes its evidence synthesis priorities annually — proposals that align with stated priorities score significantly higher.
• Pipeline to Proposal Awards: Capacity-building grants ($50K–$200K) designed for institutions or teams without prior PCORI funding that need support to develop a competitive full application. Priority given to organizations serving populations underrepresented in research. This is the right entry point if your team has the clinical expertise but hasn't done PCORI-style patient engagement or pragmatic trial design before.

The Patient Engagement Requirement: What Reviewers Actually Want to See

PCORI has been explicit about the minimum standard for patient engagement — and explicit that engagement that happens after the protocol is written doesn't count. The agency expects patient partners to be involved in: identifying and refining the research question, selecting outcomes that matter to patients, contributing to study design decisions (particularly eligibility criteria and outcome measures), interpreting results in context of patient experience, and co-creating dissemination materials.

• The Patient and Stakeholder Engagement Plan is a scored, required section of every PCORI application — not supplementary material. Reviewer scores on engagement quality directly affect funding decisions.
• PCORI provides a Patient Engagement Rubric and Checklist (available on pcori.org) that maps exactly to what reviewers evaluate. Use it to audit your engagement plan before submission.
• Patient partners must be compensated at rates appropriate to their expertise and time commitment. Underpaying patient partners is both ethically inconsistent with PCORI's stated values and a red flag for reviewers assessing whether your engagement is genuine.
• Document the engagement you've already done. Applications that describe what you plan to do with patients perform worse than those that show what you've already done with them during proposal development.

Application Process: Five Steps

• Step 1 — Review the current funding announcement on pcori.org/funding. Each announcement specifies priority populations, clinical areas, and study design requirements for that cycle. The Q2 2026 announcements updated the priority populations since Q4 2025 — don't assume the previous cycle's framing applies. The PCORI research agenda document is essential reading before you start writing.
• Step 2 — Attend the funding opportunity webinar. PCORI hosts webinars for each funding announcement. These are not optional background sessions — they include explicit guidance on what previous reviewer panels flagged as weaknesses, what the current priority emphases are, and what common errors look like in each section. Investigators who skip the webinar submit weaker proposals.
• Step 3 — Submit a Letter of Intent (LOI). Most PCORI mechanisms require a 2–3 page LOI before a full application is invited. PCORI provides written feedback on LOIs. The feedback is substantive and worth acting on — a LOI that receives "not recommended for full application" feedback can be revised and resubmitted if the issues are addressable. Don't skip the LOI feedback step.
• Step 4 — Build the full application around the five core sections: Research Plan (population, comparators, outcomes, design, analysis), Patient and Stakeholder Engagement Plan, Dissemination and Implementation Plan, Budget and Justification, and Team Qualifications. The Dissemination section is more important at PCORI than at NIH — reviewers assess whether you have a credible plan for getting your results into clinical practice, not just published in journals.
• Step 5 — Submit through PCORI's portal at pcori.org. PCORI does not use Grants.gov. Register early — the portal registration process for multi-investigator applications with institutional sign-off requires more lead time than most investigators expect.